LSTA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Based on the provided data, Lisata Therapeutics Inc (LSTA) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of significant positive catalysts, weak financial performance, and no clear trading signals suggest holding off on buying this stock at this time.
The stock's MACD is negative and expanding (-0.0858), indicating bearish momentum. RSI is neutral at 57.482, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 4.604, R1: 4.696, S1: 4.512, R2: 4.752, S2: 4.456. Overall, technical indicators are mixed, with no strong buy signals.
NULL identified. No recent news, no significant insider or hedge fund activity, and no recent congress trading data.
Weak financial performance in Q3 2025, with net income dropping by -13.81% YoY and EPS declining by -16.95% YoY. The stock has a 50% chance of declining -4.52% in the next week based on similar candlestick patterns.
In Q3 2025, revenue remained at 0 with no YoY growth. Net income dropped to -$4,249,000 (-13.81% YoY), and EPS declined to -0.49 (-16.95% YoY). Gross margin remained at 100%, showing no improvement.
No analyst rating or price target changes provided. Wall Street sentiment is neutral, with no significant pros or cons identified.
